Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer

Detalles Bibliográficos
Autores principales: De Giglio, Andrea, Di Federico, Alessandro, Metro, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554691/
https://www.ncbi.nlm.nih.gov/pubmed/36248330
http://dx.doi.org/10.21037/tlcr-22-492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554691/
https://www.ncbi.nlm.nih.gov/pubmed/36248330
http://dx.doi.org/10.21037/tlcr-22-492

Ejemplares similares